KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) on Monday banned the sale and use of Famila injection, a contraceptive injection found to be substandard and potentially harmful for females.
After confirming that a specific batch of the contraceptive injection did not meet safety standards, the central drug testing lab flagged the product – manufactured by Zafa Pharmaceutical Karachi.
In response, DRAP has issued a product recall alert, urging the removal of the affected Famila injection batch from the market in Karachi, as reported by ARY News.
The alert underlines that using the substandard batch may pose serious health risks, including blood infections.
DRAP has instructed the National Regulatory Field Force to enhance surveillance and seize the affected stock from pharmacies across Karachi.
Pharmacies have been directed to dispose the inventory from this batch, and the manufacturer is required to halt distribution and recall the already distributed supplies.
DRAP has also cautioned doctors and patients against using this batch of Famila injection, reinforcing its commitment to public health and safety.
